Biological
COVID-19 exposure
COVID-19 exposure is a biological therapy with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Terminated(1)
Detailed Status
Completed1
Withdrawn1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Trials by Status
completed133%
withdrawn133%
recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
completed
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759
recruiting
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
NCT05553743
withdrawn
The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury
NCT04340921
Clinical Trials (3)
Showing 3 of 3 trials
NCT04659759
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT05553743
Researchers At UC San Diego Are Learning About the Benefits of Human Milk and How It Influences Infant and Child Health
NCT04340921
The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury
All 3 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 3